A Multicenter Study of Anlotinib in Hepatocellular Carcinoma (HCC) Patients at High Risk of Post Surgery Recurrence
Clinical trial NCT03945799 · TERMINATED
Trial details
- NCT number
- NCT03945799
- Sponsor
- Zhejiang University
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-22
- Primary completion
- 2022-06-25
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.